Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
AB

Adrian Bot — 22 Patents

MAMannkind: 8 patents #32 of 146Top 25%
KPKite Pharma: 7 patents #3 of 43Top 7%
NTNektar Therapeutics: 2 patents #104 of 250Top 45%
Beverly Hills, CA: #48 of 914 inventorsTop 6%
California: #25,951 of 386,348 inventorsTop 7%
Overall (All Time): #189,202 of 4,157,543Top 5%
22 Patents All Time
Adrian Bot has been granted 22 US patents while listed as an inventor at Mannkind. The first was granted in 2001 and the most recent in November 2025. Adrian Bot ranks #189,202 of 4,157,543 US inventors in our database (top 4.6%). Patent records list Adrian Bot in Beverly Hills, CA, US.

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12480951 Methods and compositions for T cell therapy Justin Budka, Szu-Ting Chou, Francesca Milletti, Vicki Plaks, John Rossi 2025-11-25
12458654 Methods of conditioning patients for T cell therapy Jeffrey S. Wiezorek, William Go, Rajesh Jain, James N. Kochenderfer, Steven A. Rosenberg 2025-11-04
12252701 Chimeric antigen receptor T cell therapy Michael David Mattie 2025-03-18
12156887 Chimeric receptor T cell treatment using characteristics of the tumor microenvironment John Rossi 2024-12-03
11779601 Diagnostic methods for T cell therapy Jeffrey S. Wiezorek, William Go, Rajul JAIN, James N. Kochenderfer, Steven A. Rosenberg 2023-10-10
11491187 Methods of conditioning patients for T cell therapy Jeffrey S. Wiezorek, William Go, Rajul JAIN, James N. Kochenderfer, Steven A. Rosenberg 2022-11-08
11357796 Treatment using chimeric receptor T cells incorporating optimized polyfunctional T cells John Rossi 2022-06-14
10322146 Methods of conditioning patients for T cell therapy Jeffrey S. Wiezorek, William Go, Rajul JAIN, James N. Kochenderfer, Steven A. Rosenberg 2019-06-18
9855298 Methods of conditioning patients for T cell therapy Jeffrey S. Wiezorek, William Go, Rajul JAIN, James N. Kochenderfer, Steven A. Rosenberg 2018-01-02
8809290 Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells Lilin Wang, Dan Smith, William Joseph Phillips, Jr., Luis A. Dellamary 2014-08-19
8703142 Methods to bypass CD4+ cells in the induction of an immune response David C. Diamond 2014-04-22 $59,690,000
8674081 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma Zhiyong Qiu 2014-03-18
8653237 Peptide analogues Liping Liu, David C. Diamond 2014-02-18 $36,551,000
8354380 NY-ESO-1 peptide analogs Liping Liu, David C. Diamond 2013-01-15 $10,927,000
8084592 Multivalent entrain-and-amplify immunotherapeutics for carcinoma Chih-Sheng Chiang, David C. Diamond, Jian Ping Gong, Kent Smith, Liping Liu +2 more 2011-12-27 $5,720,000
7999088 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma Zhiyong Qiu 2011-08-16 $5,553,000
7605227 Melanoma antigen peptide analogues Liping Liu, David C. Diamond 2009-10-20 $13,041,000
7511119 PRAME peptide analogues Liping Liu, David C. Diamond 2009-03-31 $4,466,000
7511118 PSMA peptide analogues Liping Liu, Jian Ping Gong, David C. Diamond 2009-03-31 $4,466,000
7141236 Methods and compositions for delivering macromolecules to or via the respiratory tract Luis A. Dellamary, Dan Smith 2006-11-28 $11,592,000
6630169 Particulate delivery systems and methods of use Thomas E. Tarara, Jeffry Weers, Alexev Kabalnov, Ernest G. Schutt, Luis A. Dellamary 2003-10-07 $11,792,000
6204250 Immunization of infants Constantin Bona 2001-03-20